Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Mon 11:33
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech Oct 19 (Reuters) - Hong Kong-listed Metis TechBio 7666.HK on Monday said it has entered a collaboration agreement with Eli Lilly LLY.N worth up to $1.1 billion for the research and development of tissue-specific drug delivery technologies.
(Reporting by Nikita Maria Jino in Bengaluru; Editing by Joyjeet Das)
Recent news on Metis TechBio
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
HK-listed Metis TechBio climbs on deal with Eli Lilly
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion (updated)
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech